- Forums
- ASX - By Stock
- ATX
- Ann: First Patient Recruited to ACCENT Trial in Pancreatic Cancer
Ann: First Patient Recruited to ACCENT Trial in Pancreatic Cancer, page-27
Featured News
Add ATX (ASX) to my watchlist
(20min delay)
|
|||||
Last
9.8¢ |
Change
-0.001(1.01%) |
Mkt cap ! $35.10M |
Open | High | Low | Value | Volume |
10.0¢ | 10.0¢ | 9.7¢ | $39.76K | 404.0K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 35000 | 9.7¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
9.8¢ | 19833 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 35000 | 0.097 |
3 | 126000 | 0.096 |
2 | 58925 | 0.095 |
3 | 119100 | 0.094 |
2 | 195215 | 0.093 |
Price($) | Vol. | No. |
---|---|---|
0.098 | 19833 | 1 |
0.099 | 190000 | 2 |
0.100 | 5017658 | 3 |
0.105 | 428653 | 7 |
0.110 | 289621 | 4 |
Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
Featured News
ATX (ASX) Chart |
The Watchlist
BTH
BIGTINCAN HOLDINGS LIMITED
David Keane, Co-Founder & CEO
David Keane
Co-Founder & CEO
Previous Video
Next Video
SPONSORED BY The Market Online